Countdown on to Adalta Trial Results, page-11

What it is exactly in this phase 1 trial in health volunteers that you are expecting to be "high impact"? I think investors remember loud and clear that it has taken years and 45 million dollars to get to this place and that's the very reason not many people want to invest here.

As far as I can see the company has just stuffed around since 2021 when they initially shelved the IV route to pivot to inhaled, and then shelved that and pivoted back to IV.

I fail to see how any deals will be struck on phase 1 results, when essentially the same results were known in 2021 and will just be replicated at a higher dose...